Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of repetitive levosimendan treatment on clinical outcomes of chronic heart failure patients
2016-004193-18Phase 4Completed
- Sponsor
- Semmelweis University Heart and Vascular Center
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of levosimendan in chronic heart failure (CHF), ischaemic cardiomyopathy (ICM) and Cardiomyopathies, sponsored by Semmelweis University Heart and Vascular Center. Primary endpoint: Quality of life (Kansas City Cardiomyopathy Questionnaire). Started Oct 2016; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)ischaemic cardiomyopathy (ICM)Cardiomyopathies
Beyond the preview
Go deeper on 2016-004193-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004193-18.